Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...

When we learned about the BBBRC in 2021, North Carolina’s life sciences manufacturing was at a critical point. More than ...

The North Carolina Biotechnology Center awarded 14 grants and loans totaling $1,287,335 to bioscience companies, universities ...

Innovate Carolina will announce the formation of a National Academy of Inventors Chapter at UNC and celebrate the accomplishments of UNC’s first class of inductees into the UNC NAI Chapter. These ...

The new STTR grant will support the next phase of research, which will transition the radioisotope to copper-67 for potential therapeutic applications. Working with Lapi, Oncurie plans to optimize and ...

Join Johnson & Johnson on Monday, December 16, for a Virtual Open House to learn more about its new Innovate Medicine Site being built in Wilson NC. Attend this virtual event to learn more about ...

An Asheville specialty pharmaceutical company is working to transform a century-old medical procedure into a treatment for migraine relief that patients can easily perform at home. Olfax Medical has ...

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.

Jonathon Lawrie, Ph.D., has re-joined the North Carolina Biotechnology Center as executive director of the Western Office in Asheville, as a result of Dale Carroll’s decision to leave the post to ...